| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/20/2009 | EP2059500A2 Inhibitors of zinc proteases thioaryl substituted and their use |
| 05/20/2009 | EP2059496A1 Acetylenic compounds |
| 05/20/2009 | EP2059254A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 05/20/2009 | EP2059250A2 Compounds for the treatment of angiogenesis |
| 05/20/2009 | EP2059236A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 05/20/2009 | EP2059233A2 Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses therof |
| 05/20/2009 | EP2059138A1 Polyphenol extraction process |
| 05/20/2009 | EP2059136A1 Apples with high polyphenolic content |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1231910B1 Pentamidine for treating cancer |
| 05/20/2009 | EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/20/2009 | EP1052974B1 Pharmaceutical formulation containing epothilone |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007054877A1 Use of hyaluronidase e.g. as a drug for the treatment of profibrotic metabolic disorder, fibrotic liver disease, chronic viral liver disease, portal hypertension, chronic hepatitis C and hepatocellular carcinoma |
| 05/20/2009 | CN101437942A Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides |
| 05/20/2009 | CN101437852A Anti-TAT226 antibodies and immunoconjugates |
| 05/20/2009 | CN101437851A Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 05/20/2009 | CN101437831A Ruthenium (II) compounds |
| 05/20/2009 | CN101437820A Heterobicyclic pyrazole compounds and methods of use |
| 05/20/2009 | CN101437818A Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors |
| 05/20/2009 | CN101437812A Quinoline derivatives for treating cancer |
| 05/20/2009 | CN101437811A Quinoline derivatives |
| 05/20/2009 | CN101437810A Quinazoline derivatives |
| 05/20/2009 | CN101437797A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437796A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437531A Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer |
| 05/20/2009 | CN101434654A Neutralizing antibody against HGF and neutralizing antibody binding to the same |
| 05/20/2009 | CN101434650A Bursa pentapeptide, deriving peptide thereof and use thereof |
| 05/20/2009 | CN101434648A Peptide for inhibiting angiogenesis, and use thereof in angiogenesis medicament preparation |
| 05/20/2009 | CN101434635A Water-soluble phenolic triterpenoid with antineoplastic activity and preparation thereof |
| 05/20/2009 | CN101434631A Estra nitrate ester medicament for inhibiting angiogenesis |
| 05/20/2009 | CN101434629A SiRNA sequence inhibiting human Akt2 gene expression and fusion expression vector |
| 05/20/2009 | CN101434622A Antimony triphenyl complexes, as well as preparation method and application thereof |
| 05/20/2009 | CN101434616A Organotin Schiff base coordination compound, as well as preparation method and application thereof |
| 05/20/2009 | CN101434600A Curcumin piperidone analog and use thereof in anti-tumor medicament |
| 05/20/2009 | CN101434592A Novel flavonoid extracted from Maackia amurensis |
| 05/20/2009 | CN101434580A Mesaconitine acylated product nitrous oxide, preparation and use |
| 05/20/2009 | CN101434579A Fuziline esterification derivative, synthetic method and use |
| 05/20/2009 | CN101434525A 4-(4-hydroxy3-methoxybenzene methyl) curcumin and use thereof in preparing anti-tumor medicament |
| 05/20/2009 | CN101434524A 4-(4-hydroxy-3-methoxybenzene methylene) curcumin, preparation thereof and use in preparing anti-cancer medicament |
| 05/20/2009 | CN101433724A Use of Akt2-siRNA fusion expression vector in preparing medicament for inhibiting metastasis of human breast cancer cell |
| 05/20/2009 | CN101433723A PH sensitivity type anticancer prodrug as well as preparation method and application thereof |
| 05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
| 05/20/2009 | CN101433720A Tumor-targeted carbon nano-tube medicament carrier and preparation thereof |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/20/2009 | CN101433696A Analgesic medicament for cancer |
| 05/20/2009 | CN101433693A Effective component of turmeric rhizome and preparation method and use thereof |
| 05/20/2009 | CN101433692A Effective component of turmeric rhizome and preparation method and use thereof |
| 05/20/2009 | CN101433691A Zedoary turmeric oil extract as well as preparation method and application thereof |
| 05/20/2009 | CN101433683A Plaster for eliminating block and relieving pain |
| 05/20/2009 | CN101433657A Toxin-expelling anticancer Chinese medicament preparation |
| 05/20/2009 | CN101433628A Chinese medicine for treating leukemia |
| 05/20/2009 | CN101433625A Compound trepang glycopeptide oral liquid |
| 05/20/2009 | CN101433614A Effective component of Chinese dittany bark as well as preparation method and use thereof |
| 05/20/2009 | CN101433613A Effective component of Chinese dittany bark as well as preparation method and use thereof |
| 05/20/2009 | CN101433612A Effective component of Chinese dittany bark as well as preparation method and use thereof |
| 05/20/2009 | CN101433592A Lupulus extract containing xanthohumol and preparation method thereof |
| 05/20/2009 | CN101433587A Effective component of Schisandra chinensis as well as preparation method and use thereof |
| 05/20/2009 | CN101433575A Chinese sapium bark seed extract and preparation method thereof |
| 05/20/2009 | CN101433571A Effective component of cowherb seed as well as preparation method and use thereof |
| 05/20/2009 | CN101433570A Effective component of cowherb seed as well as preparation method and use thereof |
| 05/20/2009 | CN101433564A Use of water chestnut extract in preparing medicament for treating leukaemia |
| 05/20/2009 | CN101433563A Effective component of chebula fruit as well as preparation method and use thereof |
| 05/20/2009 | CN101433560A Effective component of galla chinensis as well as preparation method and use thereof |
| 05/20/2009 | CN101433559A Effective component of galla chinensis as well as preparation method and use thereof |
| 05/20/2009 | CN101433558A Effective component of galla chinensis as well as preparation method and use thereof |
| 05/20/2009 | CN101433557A Effective component of galla chinensis as well as preparation method and use thereof |
| 05/20/2009 | CN101433546A Capecitabine sustained and controlled release oral formulation and preparation method thereof |
| 05/20/2009 | CN101433533A Intravenous injection emulsion of paclitaxel or polyenic taxusol |
| 05/20/2009 | CN101433529A Glycyrrhizic acid transdermal formulation and preparation technique thereof |
| 05/20/2009 | CN101433528A Method for preparing stable water dispersion xanthophyll microcapsule from xanthophyll crystal |
| 05/20/2009 | CN101433522A Method for preparing andrographolide solid dispersion |
| 05/20/2009 | CN101433520A Anticancer sustained-release agent containing epothilone |
| 05/20/2009 | CN101433515A High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 05/20/2009 | CN101433514A Curcumin-poloxamer solid dispersion as well as preparation method and application thereof |
| 05/20/2009 | CN101433513A Semi-interpenetrating network polymer gel for oral colon-specific drug release system and preparation method thereof |
| 05/20/2009 | CN100489091C Recombinant herpes simplex virus capable of excreting angiostatin and endostatin protein and its application in treating lung cancer |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |
| 05/20/2009 | CN100488965C Water soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 05/20/2009 | CN100488960C 2-substituted quinolone compound and use in pharmacy |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488946C Salts of guanidine derivatives and its pharmaceutical preparations composition |
| 05/20/2009 | CN100488568C Cell preparation capable of excreting chalone of endothelium, and application for preparing medicine for treating tumor |
| 05/20/2009 | CN100488567C Cancer gene therapeutic drug |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/20/2009 | CN100488561C Method for preparing interferon long-acting injection microsphere preparation |
| 05/20/2009 | CN100488560C Method for preparing mass micro-capsule |
| 05/20/2009 | CN100488553C Extractive of bullbrier genus plants, preparation method and application thereof |
| 05/20/2009 | CN100488527C Menyanthes root extraction and its preparation method and usage |
| 05/20/2009 | CN100488523C Medication of effective part of bee pollen form cole, preparation method and application |
| 05/20/2009 | CN100488516C Use of compound in preparing medicament for pancreatic cancer treatment |
| 05/20/2009 | CN100488512C Compositions for treatment of cell proliferative disorders and its uses |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/20/2009 | CN100488502C Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 05/20/2009 | CN100488499C Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |